» Articles » PMID: 35628509

Rearrangement in the Hypervariable Region of JC Polyomavirus Genomes Isolated from Patient Samples and Impact on Transcription Factor-Binding Sites and Disease Outcomes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 May 28
PMID 35628509
Authors
Affiliations
Soon will be listed here.
Abstract

JC polyomavirus (JCPyV) is the causative agent of the fatal, incurable, neurological disease, progressive multifocal leukoencephalopathy (PML). The virus is present in most of the adult population as a persistent, asymptotic infection in the kidneys. During immunosuppression, JCPyV reactivates and invades the central nervous system. A main predictor of disease outcome is determined by mutations within the hypervariable region of the viral genome. In patients with PML, JCPyV undergoes genetic rearrangements in the noncoding control region (NCCR). The outcome of these rearrangements influences transcription factor binding to the NCCR, orchestrating viral gene transcription. This study examines 989 NCCR sequences from patient isolates deposited in GenBank to determine the frequency of mutations based on patient isolation site and disease status. The transcription factor binding sites (TFBS) were also analyzed to understand how these rearrangements could influence viral transcription. It was determined that the number of TFBS was significantly higher in PML samples compared to non-PML samples. Additionally, TFBS that could promote JCPyV infection were more prevalent in samples isolated from the cerebrospinal fluid compared to other locations. Collectively, this research describes the extent of mutations in the NCCR that alter TFBS and how they correlate with disease outcome.

Citing Articles

Evaluating Neural Network Performance in Predicting Disease Status and Tissue Source of JC Polyomavirus from Patient Isolates Based on the Hypervariable Region of the Viral Genome.

Pike A, Amal S, Maginnis M, Wilczek M Viruses. 2025; 17(1).

PMID: 39861801 PMC: 11769028. DOI: 10.3390/v17010012.


Exploring JC Polyomavirus Sequences and Human Gene Expression in Brain Tissue of Patients With Progressive Multifocal Leukoencephalopathy.

Honkimaa A, Laine P, Suppula J, Tynninen O, Saarela M, Laakso S J Infect Dis. 2024; 230(3):e732-e736.

PMID: 38365889 PMC: 11420775. DOI: 10.1093/infdis/jiae066.


Revisiting JC virus and progressive multifocal leukoencephalopathy.

Rocchi A, Sariyer I, Berger J J Neurovirol. 2023; 29(5):524-537.

PMID: 37659983 DOI: 10.1007/s13365-023-01164-w.


Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011-2020.

Nakamichi K, Miura Y, Shimokawa T, Takahashi K, Suzuki T, Funata N Viruses. 2023; 15(4).

PMID: 37112948 PMC: 10144269. DOI: 10.3390/v15040968.


Genetic Variation in Transcription Factor Binding Sites.

Santpere G Int J Mol Sci. 2023; 24(5).

PMID: 36902467 PMC: 10003035. DOI: 10.3390/ijms24055038.


References
1.
Carson K, Evens A, Richey E, Habermann T, Focosi D, Seymour J . Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009; 113(20):4834-40. PMC: 2686134. DOI: 10.1182/blood-2008-10-186999. View

2.
Bailey T, Johnson J, Grant C, Noble W . The MEME Suite. Nucleic Acids Res. 2015; 43(W1):W39-49. PMC: 4489269. DOI: 10.1093/nar/gkv416. View

3.
Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K . Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol. 1990; 64(6):3139-43. PMC: 249511. DOI: 10.1128/JVI.64.6.3139-3143.1990. View

4.
Moens U, Johansen T, Johnsen J, Seternes O, Traavik T . Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis. Virus Genes. 1995; 10(3):261-75. DOI: 10.1007/BF01701816. View

5.
Frisque R . Nucleotide sequence of the region encompassing the JC virus origin of DNA replication. J Virol. 1983; 46(1):170-6. PMC: 255105. DOI: 10.1128/JVI.46.1.170-176.1983. View